New PET scan may solve brain tumor puzzle: regrowth or side effect?
NCT ID NCT07238322
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special type of PET scan (using a tracer called FET) can accurately tell the difference between a returning brain tumor (glioma) and harmless changes caused by previous treatment. Researchers analyzed scans from 253 patients of all ages who had already been treated for glioma and showed suspicious signs on MRI. The goal was to see if FET-PET could help doctors make better decisions without needing a biopsy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University Medical Center Utrecht
Utrecht, Netherlands
-
University Hospital Essen
Essen, Germany
-
University of California, San Francisco
San Francisco, California, 94107, United States
-
Universityhospital Tuebingen
Tübingen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves could make brain tumor diagnosis safer and smarter
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- Can a tiny implant trap brain tumor cells and make radiation work better?
- Can a targeted pill slow brain tumor growth after surgery?